Thrivent Financial for Lutherans Purchases 10,870 Shares of CVS Health Corporation $CVS

Thrivent Financial for Lutherans increased its position in CVS Health Corporation (NYSE:CVS) by 11.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 105,084 shares of the pharmacy operator’s stock after acquiring an additional 10,870 shares during the quarter. Thrivent Financial for Lutherans’ holdings in CVS Health were worth $7,922,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the last quarter. Avion Wealth raised its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Corundum Trust Company INC acquired a new stake in CVS Health during the third quarter worth about $29,000. Harbor Asset Planning Inc. bought a new position in CVS Health during the second quarter valued at about $30,000. Finally, Front Row Advisors LLC raised its holdings in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Up 1.4%

Shares of CVS opened at $76.30 on Friday. The business’s 50 day simple moving average is $78.65 and its 200-day simple moving average is $75.43. CVS Health Corporation has a one year low of $53.36 and a one year high of $85.15. The company has a market capitalization of $96.86 billion, a P/E ratio of 200.79, a PEG ratio of 0.69 and a beta of 0.50. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is currently 700.00%.

Analyst Ratings Changes

A number of analysts have recently issued reports on CVS shares. TD Cowen boosted their price objective on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Wells Fargo & Company lowered their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Mizuho increased their price objective on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Wolfe Research lifted their target price on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Finally, Piper Sandler restated an “overweight” rating and set a $101.00 price target (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.82.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.